Paper194247
Immune surveillance against virus-induced tumors and nonrejectability of spontaneous tumors: contrasting consequences of host versus tumor evolution.
Klein G and 1 other. Proc Natl Acad Sci U S A, 1977. Cited by 178 papers, by iCite.
Cite this record
ConductScience Library. Immune surveillance against virus-induced tumors and nonrejectability of spontaneous tumors: contrasting consequences of host versus tumor evolution. Papers, record 194247. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/194247
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Immune surveillance against virus-induced tumors and nonrejectability of spontaneous tumors: contrasting consequences of host versus tumor evolution.
- PubMed
Topics14
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Genes | Major topic |
| Neoplasms | Major topic |
| Tumor Virus Infections | Major topic |
| Animals | |
| Antigens, Neoplasm | |
| Antigens, Viral | |
| Burkitt Lymphoma | |
| Herpesvirus 4, Human | |
| Humans | |
| Immunity, Cellular | |
| Mice | |
| Mice, Inbred AKR | |
| Oncogenic Viruses | |
| T-Lymphocytes |
Source PubMed
References36
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 1055422 | Trisomy of chromosome 15 in spontaneous leukemia of AKR mice. | Proc Natl Acad Sci U S A | 1975 | https://conductscience.org/library/papers/1055422 | PubMed |
| 2 | 1079330 | Killer T cells in a Burkitt's lymphoma biopsy. | Nature | 1975 | https://conductscience.org/library/papers/1079330 | PubMed |
| 3 | 1080480 | Natural cytotoxic reactivity of mouse lymphoid cells against syngeneic and allogeneic tumors. II. Characterization of effector cells. | Int J Cancer | 1975 | https://conductscience.org/library/papers/1080480 | PubMed |
| 4 | 1082915 | Killer cells: a functional comparison between natural, immune T-cell and antibody-dependent in vitro systems. | J Exp Med | 1976 | https://conductscience.org/library/papers/1082915 | PubMed |
| 5 | 1086218 | "Natural" killer cells in the mouse. II. Cytotoxic cells with specificity for mouse Moloney leukemia cells. Characteristics of the killer cell. | Eur J Immunol | 1975 | https://conductscience.org/library/papers/1086218 | PubMed |
| 6 | 1150347 | Genetic variation of in vitro cytolytic activity and in vivo rejection potential of non-immunized semi-syngeneic mice against a mouse lymphoma line. | Int J Cancer | 1975 | https://conductscience.org/library/papers/1150347 | PubMed |
| 7 | 1234049 | "Natural" killer cells in the mouse. I. Cytotoxic cells with specificity for mouse Moloney leukemia cells. Specificity and distribution according to genotype. | Eur J Immunol | 1975 | https://conductscience.org/library/papers/1234049 | PubMed |
| 8 | 1257779 | From the molecular biology of oncogenic DNA viruses to cancer. | Science | 1976 | https://conductscience.org/library/papers/1257779 | PubMed |
| 11 | 13914573 | Histocompatibility genes of mice. III. H-1 and H-4, two histocompatibility loci in the first linkage group. | Immunology | 1961 | https://conductscience.org/library/papers/13914573 | PubMed |
| 12 | 165518 | Cytotoxic effector cells specific for B Cell lines transformed by Epstein-Barr virus are present in patients with infectious mononucleosis. | Proc Natl Acad Sci U S A | 1975 | https://conductscience.org/library/papers/165518 | PubMed |
| 13 | 173019 | Immunosurveillance of naturally occurring feline leukemia. | Science | 1975 | https://conductscience.org/library/papers/173019 | PubMed |
| 14 | 174397 | Horizontally and vertically transmitted oncornaviruses of cats. | Adv Cancer Res | 1975 | https://conductscience.org/library/papers/174397 | PubMed |
| 15 | 191377 | Vaccination against oncogenic herpesviruses - a review. | IARC Sci Publ (1971) | 1975 | https://conductscience.org/library/papers/191377 | PubMed |
| 16 | 322458 | Chromosomal abnormalities and their specificity in human neoplasms: an assessment of recent observations by banding techniques. | Adv Cancer Res | 1977 | https://conductscience.org/library/papers/322458 | PubMed |
| 17 | 322459 | Temperature-sensitive mutations in animal cells. | Adv Cancer Res | 1977 | https://conductscience.org/library/papers/322459 | PubMed |
| 18 | 4113130 | Marker band in one chromosome 14 from Burkitt lymphomas. | Nature | 1972 | https://conductscience.org/library/papers/4113130 | PubMed |
| 19 | 4131386 | Immunological aspects of chemical carcinogenesis. | Adv Cancer Res | 1973 | https://conductscience.org/library/papers/4131386 | PubMed |
| 20 | 4133586 | Antibody reactions to herpesvirus saimiri (HVS)-induced early and late antigens (EA and LA) in HVS-infected squirrel, marmoset and owl monkeys. | Int J Cancer | 1973 | https://conductscience.org/library/papers/4133586 | PubMed |
| 21 | 4326228 | Ciromosomal control of reversion in transformed cells. | Nature | 1971 | https://conductscience.org/library/papers/4326228 | PubMed |
| 22 | 4338345 | Tumor etiology and chromosome pattern. | Science | 1972 | https://conductscience.org/library/papers/4338345 | PubMed |
Cited by49
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 178 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 40266514 | The Tumor Immune Environment: Advances in the Cancer Immunotherapy Era. | Methods Mol Biol | 2025 | https://conductscience.org/library/papers/40266514 | PubMed |
| 36476657 | Two contrasting papers stimulate a commentary on the origins of tumour immunology, current cancer immunotherapies, and the future potential for cancer immunotherapy. | Br J Cancer | 2023 | https://conductscience.org/library/papers/36476657 | PubMed |
| 34937915 | The foundations of immune checkpoint blockade and the ipilimumab approval decennial. | Nat Rev Drug Discov | 2022 | https://conductscience.org/library/papers/34937915 | PubMed |
| 33455477 | In situ vaccination with nanoparticles for cancer immunotherapy: understanding the immunology. | Int J Hyperthermia | 2020 | https://conductscience.org/library/papers/33455477 | PubMed |
| 29805573 | Elevated peripheral blood B lymphocytes and CD3+CD4-CD8- T lymphocytes in patients with non-small cell lung cancer: A preliminary study on peripheral immune profile. | Oncol Lett | 2018 | https://conductscience.org/library/papers/29805573 | PubMed |
| 28289211 | George Klein: 1925-2016. | Proc Natl Acad Sci U S A | 2017 | https://conductscience.org/library/papers/28289211 | PubMed |
| 26690220 | Anti-Tumor Immunity in Head and Neck Cancer: Understanding the Evidence, How Tumors Escape and Immunotherapeutic Approaches. | Cancers (Basel) | 2015 | https://conductscience.org/library/papers/26690220 | PubMed |
| 26042126 | Dendritic cell-based vaccination in cancer: therapeutic implications emerging from murine models. | Front Immunol | 2015 | https://conductscience.org/library/papers/26042126 | PubMed |
| 24457417 | Tumour antigens recognized by T lymphocytes: at the core of cancer immunotherapy. | Nat Rev Cancer | 2014 | https://conductscience.org/library/papers/24457417 | PubMed |
| 23454765 | Virus-induced hepatocellular carcinomas cause antigen-specific local tolerance. | J Clin Invest | 2013 | https://conductscience.org/library/papers/23454765 | PubMed |
| 23202942 | A tumor surveillance model: a non-coding RNA senses neoplastic cells and its protein partner signals cell death. | Int J Mol Sci | 2012 | https://conductscience.org/library/papers/23202942 | PubMed |
| 22720237 | Tgf-β1 produced by activated CD4(+) T Cells Antagonizes T Cell Surveillance of Tumor Development. | Oncoimmunology | 2012 | https://conductscience.org/library/papers/22720237 | PubMed |
| 22378190 | The determinants of tumour immunogenicity. | Nat Rev Cancer | 2012 | https://conductscience.org/library/papers/22378190 | PubMed |
| 22248703 | T cell- but not tumor cell-produced TGF-β1 promotes the development of spontaneous mammary cancer. | Oncotarget | 2011 | https://conductscience.org/library/papers/22248703 | PubMed |
| 22212863 | Targeting stroma to treat cancers. | Semin Cancer Biol | 2012 | https://conductscience.org/library/papers/22212863 | PubMed |
| 21757379 | T cell surveillance of oncogene-induced prostate cancer is impeded by T cell-derived TGF-β1 cytokine. | Immunity | 2011 | https://conductscience.org/library/papers/21757379 | PubMed |
| 21714479 | Progression of cancer from indolent to aggressive despite antigen retention and increased expression of interferon-gamma inducible genes. | Cancer Immun | 2011 | https://conductscience.org/library/papers/21714479 | PubMed |
| 20842057 | Adjuvant therapy with agonistic antibodies to CD134 (OX40) increases local control after surgical or radiation therapy of cancer in mice. | J Immunother | 2010 | https://conductscience.org/library/papers/20842057 | PubMed |
| 17149595 | Immune reconstitution prevents metastatic recurrence of murine osteosarcoma. | Cancer Immunol Immunother | 2007 | https://conductscience.org/library/papers/17149595 | PubMed |
| 16873770 | Early manifestations of NNK-induced lung cancer: role of lung immunity in tumor susceptibility. | Am J Respir Cell Mol Biol | 2007 | https://conductscience.org/library/papers/16873770 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/194247
GET https://conductscience.org/api/papers/v1/194247/references?page=2